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William B. Dobyns,6 David Traver,2 Lihadh Al-Gazali,7 Bassam R. Ali,8 Tom H. Lindner,9
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Colin A. Johnson,13 Christopher Bennett,14 Francesco Brancati,15 The International Joubert
Syndrome Related Disorders (JSRD) Study Group,18 Enza Maria Valente,15 C. Geoffrey Woods,16
and Joseph G. Gleeson1,*
Joubert syndrome (JS) and related disorders are a group of autosomal-recessive conditions sharing the ‘‘molar tooth sign’’ on axial brain
MRI, together with cerebellar vermis hypoplasia, ataxia, and psychomotor delay. JS is suggested to be a disorder of cilia function and is
part of a spectrum of disorders involving retinal, renal, digital, oral, hepatic, and cerebral organs. We identiﬁed mutations in ARL13B in
two families with the classical form of JS. ARL13B belongs to the Ras GTPase family, and in other species is required for ciliogenesis, body
axis formation, and renal function. The encoded Arl13b protein was expressed in developingmurine cerebellum and localized to the cilia
in primary neurons. Overexpression of human wild-type but not patient mutant ARL13B rescued the Arl13b scorpion zebraﬁsh mutant.
Thus, ARL13B has an evolutionarily conserved role mediating cilia function in multiple organs.Introduction
Joubert syndrome (JS [MIM 213300]) is characterized by
congenital cerebellar ataxia, hypotonia, oculomotor
apraxia, andmental retardation. It is the most common in-
herited cerebellar malformation syndrome and is part of
the autosomal-recessive cerebellar ataxia group of disor-
ders.1 The neuroradiological hallmark in JS is a peculiar
malformation of the midbrain-hindbrain junction known
as the ‘‘molar tooth sign’’ (MTS), consisting of cerebellar
vermis hypoplasia or dysplasia, thick and horizontally
oriented superior cerebellar peduncles, and an abnormally
deep interpeduncular fossa.2 The MTS has subsequently
been reported in a group of syndromes termed Joubert
syndrome and related disorders (JSRD). These include (1)
classical JS (MIM 213300), (2) JS plus Leber congenital am-
aurosis (LCA, i.e., congenital retinal blindness [MIM
204000]),3 (3) JS plus nephronophthisis (NPHP [MIM
256700]), (4) JS plus LCA plus NPHP (also known as cere-
bello-oculo-renal syndrome [CORS (MIM 608091)]),4 (5)
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216360]) syndrome,5 and (6) oral-facial-digital syndrome
type VI6,7 (MIM 277170), with occurrence of other features
such as encephalocele and polydactyly variably found
within each subgroup. Many of these disorders have
previously been linked to genes encoding cilia-localized
proteins, so JSRD was considered a candidate ciliopathy
disorder. The recent discoveries that JSRD can be due to
mutations in CEP2908,9 (encoding a known centrosomal/
cilia protein), as well as mutations in NPHP110,11 (previ-
ously implicated in the NPHP ciliopathy), RPGRIP1L12–14
(encoding a binding partner of proteins implicated in the
ciliopathy retinitis pigmentosa), and TMEM67 (a.k.a.
MKS3)15 (previously implicated in the Meckel syndrome
ciliopathy) have further strengthened the hypothesis
that JSRD is due to defective ciliary function.
Here we report the identiﬁcation of the JBTS8 locus and
mutations in the ARL13B gene, encoding ADP-ribosylation
factor-like protein 13B. ARL13B is a small GTPase belong-
ing to the class of Arf/Arl family within the Ras superfamily
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ARL13B is thus the ﬁrst gene encoding an enzymatically
active protein implicated in JS, suggesting that its study
may shed light on the essential signaling pathways.
Furthermore, an Arl13b null mutation was recently identi-
ﬁed as underlying the lethal hennin mouse mutant that
displays a Sonic Hedgehog-like phenotype, as well as being
identiﬁed in the zebraﬁsh scorpion mutant that displays
renal cysts and curved tail, both tied to impaired cilia func-
tion. The identiﬁcation of ARL13B mutations in humans
with JS, together with the previous work in mouse and
zebraﬁsh, indicates an extremely broad spectrum of phe-
notypes across species all related to defective cilia function.
The results also suggest a role for cilia-mediated Sonic
Hedgehog signaling in cerebellar development and the
pathogenesis of JS in humans.Material and Methods
Genome Mapping
Family MTI-001 was recruited according to an approved Human
Subjects Protocol at the University of Leeds and UCSD. DNA was
extracted from peripheral blood leukocytes by salt extraction,
genotyped with the Illumina Linkage IVb mapping panel,16 and
analyzed with easyLINKAGE-Plus17 software, which runs Allegro
version 1.2c in a PC Windows interface to calculate multipoint
LOD scores. Parameters were set to autosomal recessive with full
penetrance, and disease allele frequency of 0.001. Genomic
regions with LOD scores over 2 were considered as candidate inter-
vals. Linkage simulations were performed with Allegro 1.2c under
the same parameters, with 500 markers at average 0.64 cM inter-
vals, codominant allele frequencies, and parametric calcula-
tions.17 Additional subjects were enrolled according to approved
protocols at University of Chicago, University of Michigan,
University of Leeds, and Necker Hospital in Paris. Control samples
were from healthy US adult subjects from a hypertension study,
from healthy Arab controls from the United Arab Emirates, and
healthy Pakistani controls from Leeds, UK.Mutation Screening
We performed direct bidirectional sequencing of the ten coding
exons and splice junction sites of ARL13B via BigDye Terminator
cycle sequencing (Applied Biosystems). We screened 124 patients
ascertained for the presence of nephronophthisis with or without
features of Joubert syndrome (courtesy of Friedhelm Hildebrandt,
U.Michigan) and32patients ascertained for thepresenceofMeckel
syndrome with or without features of Joubert syndrome (courtesy
of Tania Attie-Bitach, Necker Hospital, France) via bidirectional se-
quencing. We screened 44 patients ascertained for the presence of
Meckel syndrome with or without features of Joubert syndrome
(courtesy of Colin Johnson, U. Leeds) by LightScanner detection
(Idaho Technologies), with subsequent bidirectional sequencing
of aberrant bands. All patient samples were ascertained and man-
aged according to approved human subjects protocols.Candidate Genes and GenBank Accession Numbers
Human ARL6 has two GenBank numbers (NM_032146.1 and
NM_177976.3) encoding the same protein, but the ﬁrst encodes
a longer transcript. Human ARL13B has two GenBank numbers
(NM_144996.1andNM_144996.2)differing inthat the secondentryThe Ameris missing coding exons 2–3. Zebraﬁsh arl13B has GenBank number
NM_173272. Mouse Arl13b has GenBank number NM_026577.2.
Bioinformatics
Predicted folding and intermolecular interactions were predicted
with Swiss-Model with crystallized ARL2-GTP as a template. The
resulting ARL13B structure was manipulated and rendered with
PyMOL software by importing amino acid sequence for wild-
type and mutant and comparing the predicted hydrogen bonds.
GTP Binding Assay
Human wild-type and mutant ARL13B cDNA were cloned sepa-
rately into the pGEX 6P1 vector (GE Lifesciences), and GST-tagged
puriﬁed protein was isolated according to the manufacturer’s rec-
ommendations. Protein was retrieved from the soluble phase,
integrity veriﬁed by SDS-PAGE analysis followed by Coomassie
staining, and analyzed by circular dichroism to validate that wild-
type and mutant proteins had similar secondary structure as des-
cribed. GTP binding was performed with a ﬁlter-based assay as
described,18 with denatured (boiled for 15 min) Arl13b protein as
negative control and Rac as a positive control, and analyzed with
SigmaPlot Ver 10.0, with one-way ANOVA for statistical analysis.
Zebraﬁsh Characterization
The arl13bsco/þ line was obtained from the Zebraﬁsh International
Resource Center (ZIRC) under an approved animal protocol at
UCSD. One-cell embryos from arl13bsco/þ matings were injected
with 50 pg in vitro transcribed capped open reading frame RNA
(Ambion Message Kit) of human wild-type or mutant transcript.
After 72 hr, embryos were phenotyped by an investigator that
was blinded to the genotype, and then all embryos were subject
to genotyping for correlation.
Histology
Mouse tissue was ﬁxedwith 4% paraformaldehyde, then processed
for 15 mmcryostat sections and immunostained as described.19We
used two different rabbit polyclonal antibodies for Arl13b, one
that was recently created against a bacterially expressed GST fused
to amino acids 208–428 of murine Arl13B,19 and one created
against an internal polypeptide, which behaved similarly, so
only the ﬁrst was used for further experimentation. Neither anti-
body showed reactivity with the cilia in the hennin mutant19
(data not shown). Antibodies were used at the following concen-
trations: Arl13b, 1:2000; acetylated tubulin (Zymed 32-2700),
1:500; calbindin (Swant), 1:600. Cerebellar granule neurons were
isolated with a cell-density gradient as described,20,21 ﬁxed, and
immunostained at various time points after plating.Results
Identiﬁcation of the JBTS8 Locus at the Centromeric
Region of Chromosome 3
Inour series,weexcluded linkage toknownloci in27consan-
guineous JSRD families, supporting evidence for further ge-
netic heterogeneity. One of the largest families (MTI-001,
Figure 1A), which is of Pakistani origin and the ﬁrst to be
recruited in this study, displayed a provenMTS on brain im-
aging (Table S1 available online), provided a maximum
expectedLODscoreof3.0, anddidnotdisplayanymutationsican Journal of Human Genetics 83, 170–179, August 8, 2008 171
Figure 1. Mapping JSRD Family MTI-
001 Identified the JBTS8 Locus Contain-
ing the ARL13B Gene, Mutation of which
Produces Altered GTP Binding
(A)MTI-001 consists of a double first cousin
marriage where each of two brothers were
married twice (generation II, double hash
refers to divorce); one had two half-
brothers and one had two half-sisters, and
each of those subsequently married his/
her respective cousin (generation III).
These two couples each produced an
affected offspring (filled symbols in genera-
tion IV) as well as healthy siblings. One
affected girl from branch 1 died from related
medical complications (single hash line).
(B) Whole-genome analysis of linkage
results with chromosomal position (x axis)
and multipoint LOD scores (y axis) showing
a significant LOD score (>3) on chr. 3.
No other peaks reached this threshold for
significance.
(C) Expanded view of the candidate inter-
val showing that the linkage signal is
composed of one major peak defined by re-
combinations at rs1005343 and rs938988
SNP markers (red), thus defining a minimal
candidate interval from 107 to 112 cM.
(D) Expanded view of the candidate inter-
val on chr. 3p12.3-q12.3, encompassing
the centromere, containing 41 candidate
genes, including ARL6 and ARL13B (red).
Transcriptional direction indicated by ar-
rowheads. Genomic structure of ARL13B
consists of 10 coding exons extending
over about 70 KB of genomic sequence.
(E) Homologymodeling ofwild-typeARL13B
showing R (green) residue and predicted hy-
drogen bond (red dashed line) with D (blue)
residue that engages in GTP binding.
(F) The p.R79Q mutation is a basic polar to
neutral polar substitution (red) and is pre-
dicted to disrupt this hydrogen bond
(absent dashes indicated by red arrow).
(G) GTP binding assay via recombinant
wild-type ARL13B (green) or p.R79Q mu-
tant (red) showing altered kinetics and
binding capacity. Experiment performed
in triplicate. Error bars represent SEM. Neg-
ative control was denatured wild-type
ARL13B (black). Statistical differences ob-
served between wild-type and mutant at
500, 1000, and 2000 nM GTP concentration
(*p < 0.05, one-way ANOVA).in any of the ﬁve known JSRD genes (NPHP1, AHI1, CEP290,
MKS3, RPGRIP1L). We performed a 0.64 cM resolution ge-
nome-widescreenby the IlluminaWholeGenomeSNPLink-
age IVb panel, which deﬁned an interval of 107–112 cM
(80.0–103.3 MB) on chromosome 3p12.3-q12.3, with peak
multipoint LOD score of 3.0 termed JBTS8 (Figure 1B).172 The American Journal of Human Genetics 83, 170–179, August 8Patients from MTI-001 Have a Homozygous p.R79Q
Change in the ARL13B Gene
This interval encompassed the centromere, with 41 genes,
and markers rs1905343 and rs938988 formed the p- and
q-arm breakpoints, respectively (Figure 1C). Four genes
within this interval were listed within the cilia proteome, 2008
databases,22,23 based upon the original work that identiﬁed
these proteins as localized to or predicted to function at the
cilium,24–30 including CEP97, MINA, ARL6, and ARL13B,
and thus were considered as strong candidates
(Figure 1D). Of these, only ARL6 (ADP-ribosylation fac-
tor-like 6) had been implicated in a human disease, where
mutations are the cause of Bardet-Biedl syndrome 3
(BBS3).31,32 Because predominantly missense mutations
were identiﬁed in ARL6, and because JSRD is a phenotypi-
cally more severe disorder than BBS, we considered that
more severe mutations (such as stop codon or splice site
mutations) might be found in MTI-001. Therefore, the
seven coding exons of ARL6 were sequenced in affecteds
from this family, but no sequence changes were encoun-
tered. The ARL13B gene (also known as ARL2L1, or
Y37E3.5 in C. elegans) had previously been demonstrated
to be expressed in ciliated neurons and speciﬁcally found
to localize to the ciliary axoneme in C. elegans sensory neu-
rons,25,31 so we considered this the next-most-likely candi-
date gene. Sequence analysis identiﬁed a homozygous
c.G236A mutation in exon 3 that is predicted to lead to
a p.R79Q (positively charged to noncharged) amino acid
substitution (Figure S1). This mutation was not encoun-
tered in 288 individuals (96 of Pakistani origin, 96 individ-
uals of Arab origin, 96 ofmixedUS origin), providing>80%
power to distinguish this from a normal sequence vari-
ant,33 and suggesting that it does not represent a common
allele. Genotyping of all members of MTI-001 showed that
this homozygous mutation segregated with the phenotype
in affecteds but not in unaffecteds or obligate carriers.
Impaired GTP Binding Associated with the R79Q
Mutation
Thep.R79Qmutation identiﬁed in familyMTI-001occurred
within the highly conserved GTP-binding domain.34,35
Therefore, we questioned whether this mutation might
affect GTP binding. Because ARL13B is 36% identical
and 61% similar in amino acid sequence with ARL2, we
used the crystal structure of ARL2 to model the effect
of the p.R79Q mutation on intramolecular forces. This
modeling showed that R79 (R74 in ARL2) of the switch II
domain establishes a hydrogen bond with D30 (D25 in
ARL2) of the P loop domain. This interaction is conserved
in other ARF family proteins36 and is predicted to be dis-
rupted with alteration in amino acid charge because of
the p.R79Q substitution (Figures 1E and 1F), and as a result
might disrupt GTP binding. To test this hypothesis, we
cloned both wild-type and p.R79Q ARL13B human cDNAs
into bacterial expression vectors (Figure S2), isolated re-
combinant proteins (Figure S3), veriﬁed that both were
soluble based upon their isolation from the liquid phase
and that they had similar secondary structure based
upon similar circular dichroism analysis37 (not shown),
and then tested their ability to bind GTP in an established
in vitro binding assay.We found that the concentration for
half-maximal GTP binding by ARL13B was ~7.2 3 107 M.
At this concentration, the amount of GTP bound toThe Amerthe mutant protein was about half of the amount bound
to the wild-type protein (p< 0.05 for each of three compar-
isons), whereas negative control was just above back-
ground (Figure 1G). We conclude that the p.R79Q muta-
tion interferes with GTPase binding activity of ARL13B
and that this mutation could lead to impairment of its cilia
function.
Mutation Analysis in a JS Cohort
We tested for mutations in ARL13B within several cohorts
of JSRD. By using bidirectional sequencing, we screened
182 patients from our cohort diagnosed with JSRD and
identiﬁed two additional mutations in one family. Family
MTI-423 has one affected female displaying a proven
MTS on brain imaging (Figure S4). The affected female
displayed a compound heterozygous mutation c.G246A
(exon 3) resulting from a stop codon p.W82X from
the mother and a c.C598T (exon 5) from the father that re-
sults in a positive charged to uncharged amino acid
p.R200Cmissense mutation within the coiled-coil domain
(Figure 2A; Figure S1). This family did not display muta-
tions in any of the known JSRD genes (NPHP1, AHI1,
CEP290, TMEM67, RPGRIP1L). Each of these ARL13B sub-
stitution mutations was fully conserved across evolution
in all mammals as well as Xenopus tropicalis, Danio rerio,
and Tetraodon Nigroviridis (Figure 2B), and none of these
mutations or any other predicted functional changes
were identiﬁed by direct bidirectional sequencing of geno-
mic DNA in a cohort of 182 healthy individuals (364 chro-
mosomes). The early lethality of the henninmouse suggests
a critical role for ARL13B in early embryonic development
and may provide one explanation for the low percentage
of ARL13B mutations in the JSRD cohort and the low rep-
resentation of truncating mutations among the ARL13B
patients.
Delineation of the Phenotypic Spectrum Associated
with ARL13B Mutations
The phenotype observed in patients with identiﬁed muta-
tions consists predominantly of classical Joubert
syndrome. All patients displayed the MTS (Table S1). In
MTI-001, two affecteds each displayed a small occipital
encephalocele. In the other family, there was no occipital
encephalocele, and there were no other supratentorial
cerebral abnormalities and no renal abnormalities upon di-
agnostic ultrasound (performed on both families). Study of
urinary concentration defects may be a more sensitive
measure of early kidney involvement andwas not available
on any of these patients, so it is possible that renal symp-
toms might develop in the future. One affected from
MTI-001 (now deceased) displayed evidence of mild non-
speciﬁc pigmentary retinopathy on clinical examination,
although electroretinogram was normal on the affected
siblings, so the involvement of ARL13B in retinal function
is not yet clear. We also screened a cohort of 124 patients
with JS with nephronophthisis and a cohort of 76 patients
with overlapping Meckel syndrome with JS features. Noican Journal of Human Genetics 83, 170–179, August 8, 2008 173
Figure 2. Human Mutations in ARL13B Occur in Conserved Residues and Interfere with Evolutionarily Conserved Functions
(A) Domain structure of ARL13B protein, with GTP binding, coiled-coil, and proline-rich domains. Red indicates conserved regions
involved in GTP binding. Mutations are indicated along the top.
(B) Evolutionary conservation of ARL13B, showing that each mutated residues is conserved at least to Danio rerio (zebrafish).
(C–F) Wild-type zebrafish have straight tails and absence of cystic kidney. Noninjected arl13bsco/sco embryos have curved tails (red arrow)
and cystic kidneys (double red arrow). The arl13bsco/sco embryos injected with human wild-type ARL13B RNA show rescue of the curved tail
and absence of cystic kidney. The human p.R79Q and p.R200C mutant ARL13B RNA failed to rescue either phenotype in the majority of
embryos, although about 15%–24% showed evidence of rescued phenotype, suggesting a hypomorphic allele. A control amino acid sub-
stitution (p.S371I) in ARL13B showed a rescue effect similar to wild-type (not shown).mutation in either of these cohorts was encountered, sug-
gesting that mutations in ARL13B are restricted to the clas-
sical form of JSRD (which can include encephalocele and
retinopathy)38 and are not identiﬁable in other related
ciliopathies, at least at this level of detection.
Human Wild-Type but Not Mutated ARL13B Rescue
the Zebraﬁsh Scorpion Mutant
To test the evolutionary conservation of ARL13B, we uti-
lized zebraﬁsh (Danio rerio). Comparison of the human174 The American Journal of Human Genetics 83, 170–179, August 8and zebraﬁsh ARL13B shows 75% similarity and 59%
identity in more than 90% of the predicted amino acid
sequence. We took advantage of the scorpion zebraﬁsh
mutant in the arl13b locus.39 The arl13bsco allele is due to
a retroviral insertion into the ﬁrst exon, which inactivates
the gene, as evidenced by the ﬁnding that morpholino
antisense treatment against arl13b produced a phenocopy
of the arl13bsco/sco mutant.40 These mutants display fully
penetrant curved tail and cystic kidney phenotypes, which
are evident by 72 hr post fertilization (hpf) (n ¼ 75, Figures, 2008
2C and 2E). We tested for rescue of the phenotype upon in-
jection of RNA into 1-cell stage embryos from arl13bsco/þ3
arl13bsco/þ matings, which produce 1/4 arl13bsco/sco em-
bryos, by phenotyping the ﬁsh at 72 hpf by investigators
blinded to the genotype. Injection of RNA corresponding
to the zebraﬁsh arl13b cDNA caused complete rescue of
the phenotype, as evidenced by the fact that no mutants
were identiﬁed by this blinded genotyping protocol (n ¼
20). Injection of the human ARL13B RNA similarly rescued
the phenotype in the majority of embryos (Figures 2D and
2F). Among these mutants, the curved tail phenotype was
rescued in 97% and the cystic kidney was rescued in 88%
of embryos (n ¼ 31). There was no overt overexpression
phenotype that resulted from injection of either RNA
into wild-type sibling embryos. Thus, the ARL13B gene dis-
plays evolutionarily conserved functions at the genetic
level in embryogenesis.
In order to test the functional impairment of the patient
missensemutations, we injected RNA corresponding to the
cDNA for the human open reading frame of ARL13B, with
each of these mutations introduced into the coding region
in a similar assay. We opted to use the human rather than
the zebraﬁsh cDNA for this work, because it represented
a more stringent test of function of the human mutations.
Injection of each of these mutant RNAs resulted in
a marked reduction in rescue when compared with the
wild-type human RNA or a control nonpathogenic amino
acid substitution-containing RNA. For this control, we
chose the p.S371I transversion, because S371 is an evolu-
tionarily conserved amino acid (similar to R79 and
R200), it occurs in a part of the protein without known sec-
ondary structure, and the p.S371I alteration does not
change the charge of the residue. The curved tail pheno-
type was rescued in 17% and 24%, and the cystic kidney
phenotype was rescued in 17% and 15% of the arl13bsco/sco
mutants for the p.R79Q and p.R200C mutations, respec-
tively (n ¼ 29 for p.R79Q, 34 for p.R200C, Figures 2C–2F).
Contrarily, for the p.S371I control substitution, the curved
tail phenotype was rescued in 100% and the cystic kidney
phenotype was rescued in 91% of the arl13bsco/sco mutants
(n ¼ 11 for p.S371I, not shown). These data indicate that
the human RNA with these human pathogenic mutations
fail to function as well as the wild-type or control mutagen-
ized human RNA and suggests that these pathogenic muta-
tions at least partially impair the function of the protein
during embryogenesis, leading to the JSRD phenotype.
Arl13b Is Expressed in Organs Affected
in JS, with Protein Localized to Cilia
We next tested for expression of Arl13b in mouse tissues
that are involved in JSRD patients at the presumed time
points of affection to determine whether expression of
the protein might account for the human phenotype.
Arl13b protein was localized to cilia of all organs examined
where they are known to be present, including the devel-
oping cerebellum (Figure 3). The epithelial cells lining
the distal renal collecting ducts have well-described cilia,The Amerand we observed Arl13b staining of cilia structures within
these tubules (Figure 3A). This staining might predict
a role for Arl13b in kidney function, although none of
our patients with ARL13B mutations displayed evidence
of impaired kidney function. The retinal photoreceptor in-
ner and outer segments, corresponding to the cell body
and rhodopsin-containing disks, are bridged by a connect-
ing cilium. We observed robust Arl13b staining of the con-
necting cilium at P10 (Figure 3B), similar to many of the
proteins involved in LCA.41,42 It is interesting to note
that one of the patients with an ARL13B mutation dis-
played evidence of retinopathy (Table S1). It will be impor-
tant to follow the remaining patients to determine
whether they develop progressive involvement of these or-
gans in the future.
To test for expression in the developing cerebellum, the
major site of involvement in JSRD, we examined Arl13b
localization in postnatal mice. At the P0 time point, the
cerebellum displays well-developed folia and consists of
three well-deﬁned layers: the external granule layer (EGL),
Purkinje cell layer (PCL), and internal granule layer (IGL).
Granule neuron precursors proliferate and migrate parallel
to the surface of the cerebellum within the EGL. Postmi-
totic granule neurons then migrate radially into the cere-
bellar parenchyma and past the PCL to settle in the IGL.
We detected strong staining of cilia-like structures on gran-
ule neurons both in the EGL and IGL (Figure 3C), which is
consistent with previous serial electron microscopic
sectioning of the cerebellum,43,44 as well as recent studies
that have used staining for adenylate cyclase III to label
cilia.45,46 Staining of Arl13b across the spectrum of cerebel-
lar development in mouse demonstrated cilia-like struc-
tures in granule neuron populations, both in the EGL
and IGL (Figure S5). There was a time dependence to the
staining of cilia-like structures during cerebellar develop-
ment, with about 40%of cells showing an immunopositive
cilia at E16, dropping to less than 1% of cells by P21.
In order to be certain that these ARL13B-immunoposi-
tive structures represented cilia, we obtained sections
from the cerebellum at P0 in a transgenic mouse that
expresses EGFP fused to Centrin 2, a constitutive centro-
some/basal body marker that localizes to centrioles.47
As expected, we found that most cells in the EGL con-
tained a readily identiﬁable pair of centrioles adjacent to
the nucleus, representing the basal body. We found an
immunopositive ARL13B structure emanating from the
region surrounding the basal body in many of these cells
(Figure 3C), thereby demonstrating the spatial relationship
between the two structures and suggesting that ARL13B
marks the cilium. However, in many cells, ARL13B was
not identiﬁed near a pair of centrioles, suggesting the pos-
sibility that ARL13B stains the cilia in only a fraction of
granule neurons or that only a fraction of granule neurons
contain a cilium.
In order to differentiate between these possibilities, we
isolated cerebellar granule neuron precursors from P5
mouse by using a cell-density gradient, cultured and ﬁxedican Journal of Human Genetics 83, 170–179, August 8, 2008 175
Figure 3. Arl13b Localization in Cilia
within Kidney, Retina, and Developing
Cerebellar Granule Neurons
Boxed region indicates location of high-
power field shown in the third panel in
(A) and (B).
(A) Kidney tubule shows Arl13b-positive
cilia protruding into the lumen (arrows)
in close approximation to the epithelial
nuclei (blue, DAPI).
(B) Retina shows intense Arl13b staining
in photoreceptor connecting cilia layer
(CC, arrow).
(C) External granule layer (EGL) of P0 cere-
bellum from EGFP-Centrin 2 transgenic
mouse stained with Arl13b. EGFP-labeled
centrioles (green dots, arrow, left) are evi-
dent in many cells, defining the position of
the basal body. An Arl13b-positive cilium
projects adjacent to the basal body in
many of these cells (arrows, right).
(D) Acutely dissociated CGN showing cilia
(arrow) stained with acetylated tubulin
(green) costains with Arl13b (red). Acety-
lated tubulin also stains the microtubule
cytoskeleton (arrowhead), which is nega-
tive for Arl13b.
Abbreviations: Co, cortex; os, outer stripe
of medulla; is, inner stripe of medulla;
OM, outer medulla; IM, inner medulla;
GCL, ganglion cell layer; IPL, inner plexi-
form layer; INL, inner nuclear layer; OPL,
outer plexiform layer; ONL, outer nuclear
layer; CC, connecting cilia; OS, outer seg-
ment; P, postnatal day. Scale bar repre-
sents 20 mm in (A)–(C) and 5 mm in (D).at various time points. We found that a fraction of these
primary cultured neurons display a cilia, as evidenced by
labeling of a structure protruding from the cell body that
was positive for acetylated tubulin (Figure 3D). Although
the acetylated tubulin staining was strongly positive
in the cilia, it extended into many of the microtubules
within the cell soma. All cells with a cilium based upon
this staining also displayed immunopositivity for Arl13b,
and Arl13b staining was largely restricted to the cilia.
Thus, Arl13b appears to be a sensitive and speciﬁc marker
for the cilium in many cells including in the developing
cerebellum. The data also support a role for Arl13b in the
pathogenesis of JSRD, and thus strongly links JSRD to
other human ciliopathies.Discussion
ARL13B encodes ADP-ribosylation factor-like protein 13B
(previously known as ADP-ribosylation factor-like protein176 The American Journal of Human Genetics 83, 170–179, August 82-like 1) and belongs to the small Ras GTPase superfamily.
ADP-ribosylation factor (ARF) GTP-binding proteins are
among the best-characterized members of the Ras super-
family ofGTPases, withwell-established roles inmembrane
trafﬁcking pathways. However, the ARL proteins appear to
be functionally distinct, and many have roles in microtu-
bule function.48,49 A mutation in Arl13b was very recently
identiﬁed as the cause for the murine hennin phenotype
that displays a disrupted neural tube during embryogene-
sis.19 The encodedArl13bprotein is localized to theprimary
cilia where it presumably plays a role inmicrotubule assem-
bly or transport akin to the roles of other Arl proteins. How-
ever, the Arl13bhnn/hnn mutant is lethal at embryonic day
13.5–14.5 because of the severe cilia phenotype, thereby
precluding a more detailed analysis of later functions.
Currently, mutations are identiﬁed in CEP290 in about
40% of patients that also display NPHP and LCA,50 in
AHI1 in 10%–20% of patients mostly without NPHP,51,52
and in probably lower percentages in TMEM67, NPHP1,
and RPGRIP1L genes. Although there are two additional, 2008
JS loci (JBTS) that have been described where the causative
gene has not yet been reported,53–55 fewer than 10% of
families map to these loci.56 Thus, fewer than 50% of
patients can receive a molecular diagnosis, and genotype-
phenotype correlations subsequently are not yet clariﬁed.
Our preliminary data indicate that mutations in ARL13B
are identiﬁed probably in less than 1% of JS, akin to the
mutation frequency of ARL6 in BBS, although it will be
interesting to determine the frequency of mutations in
ARL13B among larger cohorts of JSRD patients.
Akin to the ﬁndings in BBS3, which is the only other
disease to be linked to mutations in an ARL protein, the
majority of mutations identiﬁed in ARL13B to date are mis-
sense.31,32 Additionally, our zebraﬁsh data indicate that
the missense mutations are probably hypomorphic alleles,
because expression of each missense mutation rescues the
phenotype with intermediate potency in the arl13bsco/sco
mutant. This most likely reﬂects a requirement for the pro-
tein during embryogenesis, because both Arl3 and Arl13b
mutant mice are often lethal prior to birth.19,57 Because
Arl13b has been implicated in Sonic hedgehog (Shh) sig-
naling,19 and because Shh58,59 as well as genes critical in
cilia function have been implicated in proliferation of cer-
ebellar granule neuron precursors,46,60 our data suggest
that Joubert syndrome may represent a defect in cilia func-
tion mediating Shh signaling in this proliferation, al-
though the exact signaling mechanisms and disrupted de-
velopmental pathways remain to be discovered.Supplemental Data
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